Brexpiprazole Impurities

• Schizophrenia – It helps manage symptoms like hallucinations, delusions, and disorganized thinking.
• Major Depressive Disorder (MDD) (adjunctive treatment) – Used alongside antidepressants to improve depression symptoms in patients with partial response to traditional treatment.
• It is also being studied for other psychiatric conditions, including agitation in Alzheimer’s disease.

• Brexpiprazole is not classified as a traditional mood stabilizer like lithium or valproate.
• However, it is used as an adjunct for treating depression, suggesting some mood-stabilizing effects.
• It modulates serotonin and dopamine receptors, which can help regulate mood in patients with bipolar disorder or depression.

• No, Brexpiprazole is not approved for ADHD.
• It is used for schizophrenia and depression, but not as a primary treatment for attention-deficit hyperactivity disorder (ADHD).
• Some studies suggest that dopamine-modulating drugs might help with ADHD symptoms, but Brexpiprazole is not a first-line treatment.

• Brexpiprazole and Aripiprazole (Abilify) are similar but not the same.
• Both are partial dopamine agonists but have different receptor binding profiles:
o Brexpiprazole has a lower intrinsic activity on dopamine receptors, making it less likely to cause restlessness (akathisia) or excessive stimulation.
o Aripiprazole is known for being more activating and may have a higher risk of side effects like impulsivity or restlessness.
• Brexpiprazole is often better tolerated in patients sensitive to side effects of Aripiprazole.